The Challenge of Achieving Target Drug Concentrations in Clinical Trials: Experience From the Symphony StudyHenrik Ekberg, Pierre Daloze, Richard D. Mamelok et al.|Transplantation|2009Cited by 67
CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitelyMatthias Corbascio, Henrik Ekberg, H Ekstrand et al.|Transplant Immunology|2002Cited by 42
Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice1Matthias Corbascio, Henrik Ekberg, Harish Mahanty et al.|Transplantation|2002Cited by 33
Induction of operational tolerance to discordant dopaminergic porcine xenografts1Lena C. Larsson, Håkan Widner, Matthias Corbascio et al.|Transplantation|2003Cited by 30
Simultaneous inhibition of B7 and LFA‐1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40LLena C. Larsson, Henrik Ekberg, Matthias Corbascio et al.|Xenotransplantation|2002Cited by 26